Trial Profile
A retrospective observational study to investigate blood urea Nitrogen/Creatinine ratio and response to tolvaptan in patients with decompensated heart failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Decompensated heart failure
- Focus Pharmacodynamics
- 30 Sep 2015 New trial record